Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment

Pediatric Hematology and Oncology
Funda CorapciogluAjda Mutlu

Abstract

In recent years erythropoietic agents have become important tools in the management of anemia in cancer patients, improving hemoglobin (Hb) concentrations, reducing the need for transfusion, and enhancing quality of life. In this prospective and historically controlled study, the effects of epoetin beta on Hb concentrations and red blood cell transfusion needs in children with cancer receiving chemotherapy or radiotherapy have been investigated. Epoetin beta (150 U/kg/day, 3 days a week) was given subcutaneously to 22 children with cancer when Hb concentration < or = 10 g/dL. Data from these patients were compared with those from 20 historical control patients. Hb concentrations were studied weekly in the first 9 weeks, then weekly or fortnightly thereafter. Minimum, maximum, and mean Hb concentrations, frequency of red blood cell transfusion, and the number of red cell packs given were noted. Hb concentrations in weeks 6, 8, and 11 were clearly higher in the study group than the controls. The minimum Hb concentration of the study group was significantly higher than than the control group (7.98 +/- 0.73 [6.70-9.68] g/dL and 7.24 +/- 1.40 [5.50-11.20] g/dL, respectively [p = .038]). A total of 8 units of erythrocyte suspension w...Continue Reading

References

Jun 14, 1990·The New England Journal of Medicine·C B MillerJ L Spivak
Nov 1, 1985·International Journal of Cell Cloning·S A RothmannF Fantelli
Mar 1, 1996·Pediatric Hematology and Oncology·I BolonakiM Kalmanti
Dec 24, 1997·Medical and Pediatric Oncology·P LeónL Sierrasesúmaga
Jun 17, 1998·Journal of Pediatric Hematology/oncology·M L MacMillan, M H Freedman
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C CsákiJ D Borsi
Aug 31, 2002·Medical and Pediatric Oncology·P A Voûte
Aug 31, 2002·Medical and Pediatric Oncology·Antonio Ruggiero, Riccardo Riccardi
Aug 31, 2002·Medical and Pediatric Oncology·Münevver BüyükpamukçuCanan Akyüz
Aug 31, 2002·Medical and Pediatric Oncology·Andreas Zoubek, Martina Kronberger
Aug 31, 2002·Medical and Pediatric Oncology·James Feusner, Caroline Hastings
Jul 11, 2003·Critical Reviews in Oncology/hematology·Simon Jean-Pierre Van Belle, Véronique Cocquyt
Mar 16, 2004·British Journal of Haematology·Bertrand Coiffier
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lars M WagnerVictor M Santana
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerP Soubeyran
Oct 12, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jean-François Morère
Sep 20, 2005·Critical Reviews in Oncology/hematology·Paolo PronzatoJose Mayordomo
Aug 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bassem I RazzoukWayne R Rackoff
Oct 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael HenkeFrank Pajonk
Dec 22, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R WrightMark N Levine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.